Pols Wants Answers On Colombian Drug Licensing Policy
Fifteen Democratic lawmakers on Wednesday pressed the Obama administration to explain recent reports that it discouraged the Colombian government from issuing a license that would have invalidated a Novartis cancer drug...To view the full article, register now.
Already a subscriber? Click here to view full article